• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NextCure, Inc. - Common Stock (NQ:NXTC)

6.800 +0.410 (+6.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 112,895
Open 6.380
Bid (Size) 6.530 (100)
Ask (Size) 6.850 (1,100)
Prev. Close 6.390
Today's Range 6.160 - 6.860
52wk Range 1.550 - 15.74
Shares Outstanding 2,676,110
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Friday's after-hours session. ↗
August 07, 2026
Via Chartmill
News headline image
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
August 06, 2026
From NextCure
Via GlobeNewswire

Performance

YTD
-48.8%
-48.8%
1 Month
+54.5%
+54.5%
3 Month
+100.0%
+100.0%
6 Month
-43.6%
-43.6%
1 Year
+37.9%
+37.9%

More News

Read More
Top movers in Tuesday's session ↗
August 04, 2026
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders
July 23, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
July 21, 2026
From Ademi LLP
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume. ↗
July 16, 2026
Via Chartmill
These stocks are moving in today's after hours session ↗
July 15, 2026
Via Chartmill
Unusual volume stocks are being observed in Wednesday's session. ↗
July 15, 2026
Via Chartmill
Wednesday's pre-market session: top gainers and losers ↗
July 15, 2026
Via Chartmill
News headline image
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders
July 14, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Kartoon Studios (NYSE: TOON) Enters Catalyst-Rich Growth Phase
July 14, 2026
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
July 14, 2026
Via Chartmill
News headline image
Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts
July 14, 2026
Via AB Newswire
Topics Artificial Intelligence
Discover the most active stocks in Tuesday's session. ↗
July 14, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
July 14, 2026
Via Benzinga
News headline image
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders
July 14, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
July 14, 2026
Via Benzinga
News headline image
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
July 14, 2026
From NextCure
Via GlobeNewswire
News headline image
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
June 04, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
June 01, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 07, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
May 04, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
April 21, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
April 07, 2026
From NextCure
Via GlobeNewswire
News headline image
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
March 31, 2026
From NextCure
Via GlobeNewswire

Frequently Asked Questions

Is NextCure, Inc. - Common Stock publicly traded?
Yes, NextCure, Inc. - Common Stock is publicly traded.
What exchange does NextCure, Inc. - Common Stock trade on?
NextCure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NextCure, Inc. - Common Stock?
The ticker symbol for NextCure, Inc. - Common Stock is NXTC on the Nasdaq Stock Market
What is the current price of NextCure, Inc. - Common Stock?
The current price of NextCure, Inc. - Common Stock is 6.800
When was NextCure, Inc. - Common Stock last traded?
The last trade of NextCure, Inc. - Common Stock was at 09/01/26 04:00 PM ET
What is the market capitalization of NextCure, Inc. - Common Stock?
The market capitalization of NextCure, Inc. - Common Stock is 18.20M
How many shares of NextCure, Inc. - Common Stock are outstanding?
NextCure, Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap